Company Filing History:
Years Active: 2013
Title: Jeff Stehouwer: Innovator in Triamino-Pyridine Derivatives
Introduction
Jeff Stehouwer is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds and compositions that have potential applications in medical imaging and treatment.
Latest Patents
Stehouwer holds a patent for "Compounds, compositions, methods of synthesis, and methods of treatment." This patent encompasses a series of triamino-pyridine derivatives and their labeled counterparts. The embodiments of this disclosure include methods for synthesizing these compounds, as well as their use in imaging and treatment methods related to corticotropin releasing factor type-1 (CRF1) and associated biological events. The patent also covers compositions that serve as ligands for the CRF1 receptor, which are utilized in non-invasive imaging techniques such as positron emission tomography (PET) and SPECT imaging.
Career Highlights
Stehouwer is affiliated with Emory University, where he continues to advance research in his field. His work has implications for both diagnostic and therapeutic applications, showcasing his commitment to improving healthcare through innovative solutions.
Collaborations
Throughout his career, Stehouwer has collaborated with esteemed colleagues, including Mark M Goodman and Clint Kilts. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.
Conclusion
Jeff Stehouwer's contributions to the field of pharmaceutical chemistry, particularly through his patent on triamino-pyridine derivatives, highlight his role as an innovator in medical research. His work not only advances scientific knowledge but also has the potential to improve patient outcomes through enhanced imaging and treatment methods.